{"id":"W2258102812","doi":"10.1016/j.clml.2015.07.549","title":"Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) for the upfront therapy of transplant ineligible patients with multiple myeloma","year":2015,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Bortezomib; Multiple myeloma; Melphalan; Regimen; Dexamethasone; Prednisone; Medicine; Cyclophosphamide; Oncology; Internal medicine; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004175332,0.0002099001,0.0005838241,0.0002513461,0.0004011409,0.0005452104,0.0002966625,0.0002379752,0.002029149],"category_scores_gemma":[0.0007012967,0.00009384571,0.00038055,0.0002845893,0.0001973295,0.0002648722,0.0002733339,0.0009638747,0.0002084553],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005474623,"about_ca_system_score_gemma":0.00115016,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001215107,"about_ca_topic_score_gemma":0.006692588,"domain_scores_codex":[0.9998621,0.00004709106,0.00001516081,0.00001446066,0.00002045062,0.00004070622],"domain_scores_gemma":[0.9997434,0.00006471235,0.00005649745,0.00001096736,0.00001065235,0.0001137704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.08624531,0.002719115,0.1507295,0.0009036809,0.000628308,0.003233574,0.0002947272,0.001465401,0.01738768,0.001620936,0.01329501,0.7214767],"study_design_scores_gemma":[0.0300991,0.04841315,0.7853784,0.001442311,0.00260354,0.01020427,0.0009160053,0.003423128,0.01515369,0.003906763,0.09834776,0.0001118625],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9428005,0.04275898,0.0006205776,0.003288396,0.0003800801,0.0002439987,0.0005527465,0.00006229973,0.009292367],"genre_scores_gemma":[0.9912616,0.005811248,0.0005727221,0.0006967502,0.0000942062,0.00005961291,0.0003998759,0.000005993787,0.001097921],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002029149,"threshold_uncertainty_score":0.006788194,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05295383253533732,"score_gpt":0.331341901670313,"score_spread":0.2783880691349757,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}